Vincere Biosciences is a JLABS incubator company whose mission is to develop drugs to halt the progression of Parkinson's disease (PD).
Vincere Biosciences has raised $5.0M in total funding. The most recent round was Grant. The last funding was announced in November 2025.
Vincere Biosciences's investors include Alumni Ventures, Draper Associates, Portal Innovations, Daewoong Pharmaceutical, Michael J. Fox Foundation.
Vincere Biosciences is headquartered in Cambridge, United States.
Vincere Biosciences is a JLABS incubator company whose mission is to develop drugs to halt the progression of Parkinson's disease (PD).
Vincere Biosciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vincere Biosciences — Funding & Investors." VCBacked, November 18, 2025, https://www.vcbacked.co/company/vincere-biosciences. Accessed July 19, 2026.
VCBacked. (2025). Vincere Biosciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/vincere-biosciences
{{cite web |title=Vincere Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/vincere-biosciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated